- Goals of myeloma treatment
- Current and emerging therapies for myeloma, including updates on stem cell transplantation and maintenance therapy
- Updates on side effects management
- The importance of patient-provider communications in treatment and side effects management
Asher A. Chanan-Khan, MD
Professor of Medicine, Mayo School of Medicine
Chair, Division of Hematology/Oncology
Vice Chair, Research
Chair, Clinical Research Subcommittee
Assistant Director, Center for Individualized Medicine
Department of Medicine
Click here for synchronized audio and slides.
Sponsors and Supporters
This program is sponsored by The Leukemia & Lymphoma Society and supported by grants from Celgene Corporation, Millennium: The Takeda Oncology Company andOnyx Pharmaceuticals.